Last update 11 Mar 2026

LS21031

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
LS 21031, LS-21031, LS21031
Target
PDE4
Action
inhibitors
Mechanism
PDE4 inhibitors(Phosphodieterase 4 inhibitors)
Therapeutic Areas
Nervous System Diseases
Active Indication
Depressive Disorder
Inactive Indication-
Originator Organization
Guangzhou Lansheng Jianzhi Pharmaceutical TechnologyGuangzhou Lansheng Jianzhi Pharmaceutical Technology
Active Organization
Guangzhou Lansheng Jianzhi Pharmaceutical TechnologyGuangzhou Lansheng Jianzhi Pharmaceutical TechnologySuzhou Hemeijia Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization
Guangzhou Lansheng Jianzhi Pharmaceutical TechnologyGuangzhou Lansheng Jianzhi Pharmaceutical TechnologyLivzon Pharmaceutical Group, Inc.Livzon Pharmaceutical Group, Inc.
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with LS21031
CTR20260888
/ Not yet recruitingPhase 1
评价健康参与者单次口服LS21031胶囊的安全性、耐受性及药代动力学特征的临床研究
[Translation] Clinical study evaluating the safety, tolerability, and pharmacokinetic characteristics of a single oral dose of LS21031 capsules in healthy participants.
100 Clinical Results associated with LS21031
Login to view more data
100 Translational Medicine associated with LS21031
Login to view more data
100 Patents (Medical) associated with LS21031
Login to view more data
100 Deals associated with LS21031
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Depressive DisorderPhase 1
China
Guangzhou Lansheng Jianzhi Pharmaceutical TechnologyGuangzhou Lansheng Jianzhi Pharmaceutical Technology
10 Mar 2026
Depressive DisorderPhase 1
China
Suzhou Hemeijia Pharmaceutical Co., Ltd.
10 Mar 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free